Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jan;261(1):103-113.
doi: 10.1007/s00417-022-05797-1. Epub 2022 Aug 10.

Efficacy and safety of intra-arterial thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis

Lele Huang  1 , Yujie Wang  2 , Ruijun Zhang  3
Affiliations
Meta-Analysis

Efficacy and safety of intra-arterial thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis

Lele Huang et al. Graefes Arch Clin Exp Ophthalmol. 2023 Jan.

Abstract

Purpose: To investigate the efficacy and safety of intra-arterial thrombolysis (IAT) in patients with central retinal artery occlusion (CRAO).

Methods: PubMed and EMBASE were searched for potentially eligible studies that reported IAT in CRAO patients from inception to Nov 8, 2021. Standard mean difference (SMD) was pooled to compare visual acuity (VA) at baseline with final in IAT patients. The rates and odds ratios (OR) were meta-analyzed to compare VA improvement in IAT with non-IAT patients, stratified to different times from onset to procedure, different definitions of VA improvement, and three CRAO stages. Adverse effects were recorded.

Results: Fifteen studies were included, enrolling 507 CRAO patients who received IAT and 296 CRAO patients who did not. VA was significantly improved from baseline to final VA in IAT patients (SMD [LogMAR] 0.70, 95% CI [0.51, 0.90]). VA improvement rate was higher in IAT patients than that in non-IAT (56% vs 32%, OR 3.55, 95%CI [1.74, 7.24]), with greater OR in IAT within 6 h from onset to procedure (OR 4.60, 95%CI [1.24, 16.99]) than that beyond 6 h (OR 3.36, 95%CI [1.43, 7.85]). The benefit remained consistent when VA improvement was defined as ≥ 3 lines on the Snellen chart (OR 4.68, 95%CI [2.10, 10.41]) and was even greater when CRAO was incomplete. Five patients had a symptomatic intracranial hemorrhage and 21 patients had ischemic stroke or transient ischemic attack after IAT.

Conclusions: IAT treatment has certain potential in ameliorating VA in CRAO patients, which should be balanced against cerebral complications.

Keywords: Adverse effects; Central retinal artery occlusion; Intra-arterial thrombolysis; Meta-analysis; Visual acuity.

PubMed Disclaimer

References

    1. Leavitt JA, Larson TA, Hodge DO, Gullerud RE (2011) The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol 152:820–823. https://doi.org/10.1016/j.ajo.2011.05.005 - DOI
    1. Park SJ, Choi NK, Seo KH, Park KH, Woo SJ (2014) Nationwide incidence of clinically diagnosed central retinal artery occlusion in Korea, 2008 to 2011. Ophthalmology 121:1933–1938. https://doi.org/10.1016/j.ophtha.2014.04.029 - DOI
    1. Kido A, Tamura H, Ikeda HO, Miyake M, Hiragi S, Tsujikawa A (2020) Nationwide incidence of central retinal artery occlusion in Japan: an exploratory descriptive study using the National Database of Health Insurance Claims (2011–2015). BMJ Open 24(10):e041104. https://doi.org/10.1136/bmjopen-2020-041104 - DOI
    1. Pick J, Nickels S, Saalmann F, Finger RP, Schuster AK (2020) Incidence of retinal artery occlusion in Germany. Acta Ophthalmol 2020. https://doi.org/10.1111/aos.14369 . Epub ahead of print
    1. Mac Grory B, Lavin P, Kirshner H, Schrag M (2020) Thrombolytic therapy for acute central retinal artery occlusion. Stroke 51:687–695. https://doi.org/10.1161/STROKEAHA.119.027478 - DOI

MeSH terms

Substances

LinkOut - more resources